These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26044909)

  • 1. Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies.
    Krom RJ; Bhargava P; Lobritz MA; Collins JJ
    Nano Lett; 2015 Jul; 15(7):4808-13. PubMed ID: 26044909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.
    Westwater C; Kasman LM; Schofield DA; Werner PA; Dolan JW; Schmidt MG; Norris JS
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1301-7. PubMed ID: 12654662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.
    Lu TK; Collins JJ
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4629-34. PubMed ID: 19255432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of antibiotic resistance in E. coli with engineered phage bearing small regulatory RNAs.
    Libis VK; Bernheim AG; Basier C; Jaramillo-Riveri S; Deyell M; Aghoghogbe I; Atanaskovic I; Bencherif AC; Benony M; Koutsoubelis N; Löchner AC; Marinkovic ZS; Zahra S; Zegman Y; Lindner AB; Wintermute EH
    ACS Synth Biol; 2014 Dec; 3(12):1003-6. PubMed ID: 25524110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
    Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM
    Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagemid vectors for phage display: properties, characteristics and construction.
    Qi H; Lu H; Qiu HJ; Petrenko V; Liu A
    J Mol Biol; 2012 Mar; 417(3):129-43. PubMed ID: 22310045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Linear Low-Cationic Peptides to Target Methicillin-Resistant Staphylococcus aureus in Vivo.
    Liu Y; Song M; Ding S; Zhu K
    ACS Infect Dis; 2019 Jan; 5(1):123-130. PubMed ID: 30372023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a P1 phagemid system for the delivery of DNA into Gram-negative bacteria.
    Westwater C; Schofield DA; Schmidt MG; Norris JS; Dolan JW
    Microbiology (Reading); 2002 Apr; 148(Pt 4):943-950. PubMed ID: 11932441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial and Antibiofilm Activities of Helical Antimicrobial Peptide Sequences Incorporating Metal-Binding Motifs.
    Agbale CM; Sarfo JK; Galyuon IK; Juliano SA; Silva GGO; Buccini DF; Cardoso MH; Torres MDT; Angeles-Boza AM; de la Fuente-Nunez C; Franco OL
    Biochemistry; 2019 Sep; 58(36):3802-3812. PubMed ID: 31448597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections.
    Wang Y; Ding X; Chen Y; Guo M; Zhang Y; Guo X; Gu H
    Biomaterials; 2016 Sep; 101():207-16. PubMed ID: 27294538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
    Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
    Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scoping the effectiveness and evolutionary obstacles in using plasmid-dependent phages to fight antibiotic resistance.
    Ojala V; Mattila S; Hoikkala V; Bamford JKh; Hiltunen T; Jalasvuori M
    Future Microbiol; 2016 Aug; 11():999-1009. PubMed ID: 27503765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part II: In vitro antimicrobial activity evaluation of a bacteriophage cocktail and several antibiotics.
    Santos TM; Gilbert RO; Caixeta LS; Machado VS; Teixeira LM; Bicalho RC
    J Dairy Sci; 2010 Jan; 93(1):105-14. PubMed ID: 20059909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria.
    Vaks L; Benhar I
    Methods Mol Biol; 2011; 726():187-206. PubMed ID: 21424451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance.
    Ghosh C; Sarkar P; Issa R; Haldar J
    Trends Microbiol; 2019 Apr; 27(4):323-338. PubMed ID: 30683453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophages displaying anticancer peptides in combined antibacterial and anticancer treatment.
    Dąbrowska K; Kaźmierczak Z; Majewska J; Miernikiewicz P; Piotrowicz A; Wietrzyk J; Lecion D; Hodyra K; Nasulewicz-Goldeman A; Owczarek B; Górski A
    Future Microbiol; 2014; 9(7):861-9. PubMed ID: 25156375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Peptides: the Achilles' Heel of Antibiotic Resistance?
    Lewies A; Du Plessis LH; Wentzel JF
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):370-381. PubMed ID: 30229514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.